Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

V David Goeddel


  • Large Shareholder, Director at Ngm Biopharmaceuticals Inc (NGM), 2019-11-13
  • Large Shareholder, Director at Rapt Therapeutics Inc. (RAPT), 2019-11-04
  • Large Shareholder at Constellation Pharmaceuticals Inc (CNST), 2019-10-07
  • Large Shareholder, Other at Immune Design Corp. (IMDZ), 2019-04-03
  • Other at Gritstone Oncology Inc. (GRTS), 2018-10-02
  • Large Shareholder at Arcus Biosciences Inc. (RCUS), 2018-03-19
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
NGM $12.00 15 Large Shareholder, Director 16,610,829 2019-11-11 Filing
NGM $11.99 8,409 Large Shareholder, Director 16,610,814 2019-11-04 Filing
RAPT $12.00 625,000 Large Shareholder, Director 4,982,333 2019-11-04 Filing
NGM $11.86 2,087 Large Shareholder, Director 16,602,405 2019-10-23 Filing
NGM $12.00 2,300 Large Shareholder, Director 16,600,318 2019-10-22 Filing